Skip to content
A Secure Online Service from Utah.gov

Utah.gov

Public Notice Website

Division of Archives and Records Service

State Medicaid DUR Board Meeting

Subscribe to Public Body

General Information

Government Type
State Agency
Entity
Department of Health and Human Services (DHHS)
Public Body
Drug Utilization Review Board

Notice Information

Add Notice to Calendar

Notice Title
State Medicaid DUR Board Meeting
Notice Type(s)
Meeting
Event Start Date & Time
October 8, 2026 07:15 AM
Event End Date & Time
October 8, 2026 08:30 AM
Event Deadline Date & Time
10/08/26 08:30 AM
Description/Agenda
Drug Utilization Review Board Meeting Agenda Thursday, October 8, 2026 7:15 a.m. to 8:30 a.m. Google Meet joining info Video call link: meet.google.com/qbv-rjpz-fst Or dial: (US) +1 314-474-3014 PIN: 334 496 072# Persons who wish to address the DUR Board may contact Luis Moreno at lmoreno@utah.gov at least one week prior to the meeting. A required conflict of interest form must be submitted by the Thursday before the meeting at 12 pm (Mountain Time). Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order - Sharon Weinstein, MD a) Welcome b) Review and Approval of Minutes c) Housekeeping - Luis Moreno, PharmD 2) Prior Authorization Updates - Luis Moreno, PharmD 3) P&T Committee Update - Ngan Huynh, PharmD 4) Annual Training: Utah Open and Public Meetings Act - Clover Meaders 5) Review Topic a) Biologics for the Treatment of Rheumatoid Arthritis and Psoriatic Arthritis: Role as First-Line Disease Modifying Therapy - Monet Luloh, PharmD i) Board Discussion/Questions ii) Board Action 6) Public Comment 7) Review New Prior Authorization Criteria a) Olumiant (baricitinib) - Iris Wan, PharmD i) Board Discussion/Questions ii) Board Action b) Simponi, Simponi Aria (golimumab) - Kyu Yun Park, PharmD i) Board Discussion/Questions ii) Board Action c) Bixlenvo (bictegravir and lenacapavir - Ngan Huynh, PharmD i) Board Discussion/Questions 8) Next Meeting a) Date: November 12, 2026 b) Topic: review Journavx utilization, and new prior authorization criteria for Baxfendy and Zoryve. 9) Adjourned - Sharon Weinstein, MD
Notice of Special Accommodations (ADA)
In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
Notice of Electronic or Telephone Participation
Video call link: meet.google.com/qbv-rjpz-fst Or dial: (US) +1 314-474-3014 PIN: 334 496 072#

Meeting Information

Meeting Location
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps
Contact Name
Luis Moreno
Contact Email
lmoreno@utah.gov
Contact Phone
801-538-6155

Notice Posting Details

Notice Posted On
September 24, 2026 04:11 PM
Notice Last Edited On
September 24, 2026 04:25 PM
Deadline Date
October 8, 2026 08:30 AM



Subscribe

Subscribe by Email

Subscription options will send you alerts regarding future notices posted by this Body.